# Test Results: synthesis-across-papers.md

## Test Metadata
- **Prompt:** literature/synthesis-across-papers.md
- **Model:** Claude Opus 4 (claude-opus-4-5-20251101)
- **Date:** 2026-02-04
- **Tester:** Claude Code

## Test Input Used

Standard test input from prompt file:

```
Context: I am synthesizing literature on antibiotic effects on the gut microbiome for a review section. I have read the following papers and am providing summaries below.

Papers provided:

**Paper 1 Summary:**
Anderson et al. (2023). "Broad-spectrum antibiotics cause rapid and persistent microbiome disruption in healthy adults."
- Study: 30 healthy adults given 7-day amoxicillin course
- Finding: 50% reduction in bacterial diversity within 3 days
- Recovery: Partial recovery by 30 days, but some taxa remained depleted at 90 days
- Notable: Proteobacteria expanded during treatment; Bacteroides recovery was slowest

---
**Paper 2 Summary:**
Martinez & Lee (2022). "Microbiome resilience varies by antibiotic class and host factors."
- Study: Meta-analysis of 12 studies (n=340 total subjects)
- Finding: Macrolides caused less diversity loss than fluoroquinolones
- Recovery: Younger subjects (<40) showed faster recovery (mean 21 days vs 45 days)
- Notable: Prior antibiotic exposure associated with slower recovery

---
**Paper 3 Summary:**
Thompson et al. (2024). "Probiotic co-administration does not prevent antibiotic-induced dysbiosis."
- Study: RCT, 60 subjects, probiotic vs placebo during antibiotic treatment
- Finding: No significant difference in diversity loss between groups
- Recovery: Similar recovery trajectories in both arms
- Notable: Probiotic strains did not engraft during antibiotic treatment

Synthesis focus: What is known about microbiome recovery after antibiotic exposure?

My specific research question: Whether there are interventions that could accelerate microbiome recovery.
```

## Filled Prompt

```
Context: I am synthesizing literature on antibiotic effects on the gut microbiome for a review section. I have read the following papers and am providing summaries below.

Papers provided:

**Paper 1 Summary:**
Anderson et al. (2023). "Broad-spectrum antibiotics cause rapid and persistent microbiome disruption in healthy adults."
- Study: 30 healthy adults given 7-day amoxicillin course
- Finding: 50% reduction in bacterial diversity within 3 days
- Recovery: Partial recovery by 30 days, but some taxa remained depleted at 90 days
- Notable: Proteobacteria expanded during treatment; Bacteroides recovery was slowest

---
**Paper 2 Summary:**
Martinez & Lee (2022). "Microbiome resilience varies by antibiotic class and host factors."
- Study: Meta-analysis of 12 studies (n=340 total subjects)
- Finding: Macrolides caused less diversity loss than fluoroquinolones
- Recovery: Younger subjects (<40) showed faster recovery (mean 21 days vs 45 days)
- Notable: Prior antibiotic exposure associated with slower recovery

---
**Paper 3 Summary:**
Thompson et al. (2024). "Probiotic co-administration does not prevent antibiotic-induced dysbiosis."
- Study: RCT, 60 subjects, probiotic vs placebo during antibiotic treatment
- Finding: No significant difference in diversity loss between groups
- Recovery: Similar recovery trajectories in both arms
- Notable: Probiotic strains did not engraft during antibiotic treatment

Task: Synthesize these papers with respect to what is known about microbiome recovery after antibiotic exposure. Structure your synthesis as follows:

1. **Overview**: One paragraph summarizing the collective state of knowledge across these papers.

2. **Points of Agreement**: What do these papers consistently find or conclude? Be specific about which papers support each point.

3. **Points of Disagreement or Tension**: Where do findings, interpretations, or recommendations conflict? Characterize the nature of the disagreement.

4. **Methodological Comparison**: How do the approaches differ? Consider:
   - Study systems/organisms
   - Sample sizes and designs
   - Analytical techniques
   - Outcome measures

5. **Gaps and Limitations**: What questions remain unaddressed across this literature? What limitations are shared?

6. **Synthesis Statement**: Two to three sentences capturing the bottom line for whether there are interventions that could accelerate microbiome recovery.

Constraints:
- Use ONLY information from the papers I have provided
- Do NOT introduce findings, citations, or context from other sources
- When attributing a claim to a paper, be specific (e.g., "Smith et al. found..." not "studies show...")
- If papers contradict each other, present both positions without resolving the disagreement
- If you cannot determine something from the provided texts, state this explicitly

Output format: Use the numbered structure above. For Points of Agreement and Disagreement, use bullet points with specific paper attributions.
```

## Model Output

**1. Overview**

These three papers collectively indicate that antibiotic exposure causes rapid and substantial disruption to gut microbiome diversity, with recovery timelines extending from weeks to months depending on antibiotic class, patient age, and prior exposure history. The evidence suggests that current standard interventions—specifically probiotic co-administration—do not accelerate recovery, highlighting a significant gap in our ability to mitigate antibiotic-induced dysbiosis. While certain taxa recover relatively quickly, others (particularly Bacteroides) show prolonged depletion, and the factors determining individual resilience remain incompletely characterized.

**2. Points of Agreement**

- **Antibiotics cause substantial diversity loss**: Anderson et al. report 50% reduction in diversity within 3 days; Martinez & Lee's meta-analysis confirms diversity loss across multiple studies and antibiotic classes; Thompson et al. document diversity loss in both probiotic and placebo groups.

- **Recovery is incomplete at 30 days**: Anderson et al. found only partial recovery by 30 days with some taxa still depleted at 90 days; Martinez & Lee report mean recovery times of 21-45 days depending on age; Thompson et al. found recovery trajectories similar in both arms but did not report full restoration.

- **Certain taxa are particularly affected**: Anderson et al. specifically note Proteobacteria expansion during treatment and slow Bacteroides recovery. (Martinez & Lee and Thompson et al. do not provide taxon-specific data in the summaries provided.)

- **Probiotics do not prevent dysbiosis during antibiotic treatment**: Thompson et al. directly tested this and found no difference between probiotic and placebo groups in diversity loss or recovery trajectories.

**3. Points of Disagreement or Tension**

- **Recovery timeline variability**: Anderson et al. report incomplete recovery even at 90 days following amoxicillin, while Martinez & Lee report mean recovery of 21 days in younger subjects. This apparent disagreement may reflect: (a) different antibiotic classes (amoxicillin vs. macrolides/fluoroquinolones in the meta-analysis), (b) different outcome definitions for "recovery," or (c) age differences in study populations. The summaries do not provide sufficient detail to resolve which factor explains the difference.

- **What determines recovery speed**: Anderson et al. focus on taxon-specific recovery rates (Bacteroides slowest); Martinez & Lee emphasize host factors (age, prior antibiotic exposure) and antibiotic class. These are complementary rather than contradictory, but the relative importance of host vs. antibiotic vs. microbial factors is not resolved.

**4. Methodological Comparison**

| Aspect | Anderson et al. (2023) | Martinez & Lee (2022) | Thompson et al. (2024) |
|--------|----------------------|---------------------|---------------------|
| Study type | Prospective cohort | Meta-analysis | Randomized controlled trial |
| Sample size | n=30 | n=340 (12 studies) | n=60 |
| Subjects | Healthy adults | Mixed (from 12 studies) | Not specified in summary |
| Antibiotic(s) | Amoxicillin (7-day course) | Multiple classes (macrolides, fluoroquinolones) | Not specified in summary |
| Intervention tested | None (observational) | None (observational) | Probiotic vs. placebo |
| Follow-up duration | 90 days | Variable across studies | Not specified in summary |
| Primary outcome | Bacterial diversity, taxon abundance | Diversity loss, recovery time | Diversity loss, recovery trajectory |
| Analytical detail | Taxa-level changes reported | Class-level and host-factor analyses | Group comparison |

**5. Gaps and Limitations**

*Unaddressed questions across this literature:*
- **Effective interventions**: The only intervention tested (probiotics) was ineffective. No papers evaluate dietary interventions, fecal microbiota transplantation, targeted prebiotics, or autologous microbiome restoration.
- **Mechanisms of slow recovery**: Why Bacteroides recovers slowly (Anderson et al.) is not explained. Whether this reflects competitive dynamics, niche availability, or host factors is unknown.
- **Functional consequences**: None of the papers address whether prolonged dysbiosis affects host health outcomes beyond diversity metrics.
- **Individual prediction**: While Martinez & Lee identify age and prior exposure as factors, no predictive model for individual recovery is presented.
- **Long-term outcomes**: Anderson et al. follow to 90 days; whether full recovery eventually occurs or some changes are permanent is not addressed.

*Shared limitations:*
- All studies use diversity as the primary metric; functional microbiome capacity is not assessed.
- None of the summaries indicate validation of findings across diverse populations (ethnicity, geography, diet).
- Thompson et al.'s probiotic trial does not specify which strains were used or whether strain selection was optimized for survival during antibiotic exposure.

**6. Synthesis Statement**

Based on these papers, there is currently no evidence for interventions that accelerate microbiome recovery after antibiotic exposure—probiotic co-administration, the only intervention tested, was ineffective (Thompson et al.). Recovery timelines are influenced by antibiotic class (macrolides less disruptive than fluoroquinolones, per Martinez & Lee) and host factors (younger subjects recover faster), but these are not modifiable interventions. Identifying effective strategies to accelerate recovery remains an open and unaddressed question across this literature.

## Overall Assessment

- **Recommendation:** Pass
- **Notes:** The synthesis effectively integrates information across the three papers while maintaining clear attribution. The methodological comparison table appropriately marks missing information rather than fabricating it. The identification of the recovery timeline variability as a point of "tension" with possible explanations (different antibiotics, populations, outcome definitions) demonstrates appropriate critical thinking without overreaching. The synthesis statement directly addresses the user's research question with an honest assessment that no effective interventions are supported by these papers.

## Verification Steps Tested

| Verification Requirement | Result |
|-------------------------|--------|
| All paper attributions match sources | Pass—claims attributed to each paper are present in corresponding summaries |
| No introduced sources | Pass—only Anderson et al., Martinez & Lee, and Thompson et al. cited |
| Disagreements accurately characterized | Pass—recovery timeline variability correctly identified with potential explanations |
| Major findings not omitted | Pass—key findings from all three papers represented |
| Synthesis statement supported by evidence | Pass—conclusion about lack of effective interventions follows from Thompson et al.'s negative probiotic finding |
